Drug Type Small molecule drug |
Synonyms NT1021, NT-1021 |
Target |
Action agonists |
Mechanism AMPK agonists(AMP activated protein kinase agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Polycystic Kidney Diseases | Preclinical | United States | 30 Oct 2012 | |
Polycystic Kidney Diseases | Preclinical | United States | 30 Oct 2012 |